Fascaplysin exert anti-tumor effects through apoptotic and anti-angiogenesis pathways in sarcoma mice model

European Journal of Pharmaceutical Sciences

Volumn 43, Issue 4, 2011, Pages 251-259

  Yan, Xiaojun ^a   Chen, Haimin ^a   Lu, Xiaoling ^a   Wang, Feng ^b   Xu, Weifeng ^b   Jin, Haixiao ^a   Zhu, Peng ^a  

^a NINGBO UNIVERSITY   (China)

^b Lihuili Hospital   (China)

Author keywords

Apoptosis; Fascaplysin; Microarray; S180 cell; Tumor

Indexed keywords

ACTIN; CD31 ANTIGEN; CYCLINE; CYCLOPHOSPHAMIDE; FASCAPLYSIN; MESSENGER RNA; MONOCLONAL ANTIBODY;

ACUTE TOXICITY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIANGIOGENIC ACTIVITY; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER INHIBITION; CANCER MODEL; CANCER TISSUE; CELL CYCLE ARREST; CELL PROLIFERATION; CELL ULTRASTRUCTURE; CONTROLLED STUDY; CYTOSKELETON; DOWN REGULATION; DRUG EFFICACY; DRUG MECHANISM; FEMALE; GENE EXPRESSION; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; MALE; MICROARRAY ANALYSIS; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; SARCOMA; SARCOMA CELL; TRANSMISSION ELECTRON MICROSCOPY;

ACTINS; ANGIOGENESIS INHIBITORS; ANIMALS; ANTIGENS, CD31; APOPTOSIS; CELL ADHESION; CELL LINE, TUMOR; CELL PROLIFERATION; FEMALE; GENE EXPRESSION PROFILING; IMMUNOHISTOCHEMISTRY; INDOLES; MALE; MICE; MICE, INBRED ICR; NEOVASCULARIZATION, PATHOLOGIC; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROLIFERATING CELL NUCLEAR ANTIGEN; SARCOMA;

EID: 79959619770     PISSN: 09280987     EISSN: 18790720     Source Type: Journal    
DOI: 10.1016/j.ejps.2011.04.018     Document Type: Article

References (28)

1. A. Balmain, J. Gray, and B. Ponder The genetics and genomics of cancer Nat. Genet. 33 2003 238 244 (Pubitemid 36278834)
2. A. Brazma, P. Hingamp, J. Quackenbush, G. Shelock, P. Spellman, C. Stoeckert, J. Aach, W. Ansorge, C. Ball, H.C. Causton, I.F. Kim, V. Markowitz, J.C. Matese, H. Parkinson, A. Robinson, U. Sarkans, S. Schulze-kremer, J. Stewart, R. Taylor, J. Vilo, and M. Vingron Minimum information about a microarray experiment (MIAME)-toward standards for microarray data Nat. Genet. 29 2001 365 371 (Pubitemid 34326681)
3. J.D. Bretz, E. Mezosi, T.J. Giordano, P.G. Gauger, N.W. Thompson, and J.R. Baker Inflammatory cytokine regulation of TRAIL-mediated apoptosis in thyroid epithelial cells Cell Death Differ. 9 2002 274 286 (Pubitemid 34223871)
4. F. Ciardiello, T. Troiani, R. Bianco, M. Orditura, F. Morgillo, E. Martinelli, M.P. Morelli, T. Cascone, and G. Tortora Interaction between the epidermal growth factor receptor (EGFR) and the vascular endothelial growth factor (VEGF) pathways: a rational approach for multi-target anticancer therapy Ann. Oncol. 17 2006 vii109 vvii114
5. A.V. Deepak, and B.P. Salimath Antiangiogenic and proapoptotic activity of a novel glycoprotein from U. Indica is mediated by NF-κB and caspase activated DNase in ascites tumor model Biochimie 88 2006 297 307
6. D.R. Dietrich Toxicological and pathological applications of proliferating cell nuclear antigen (PCNA), a novel endogenous marker for cell proliferation Crit. Rev. Toxicol. 23 1993 77 109 (Pubitemid 23094395)
7. Y. Guo, H. Guo, L. Zhang, H. Xie, X. Zhao, F. Wang, Z. Li, Y. Wang, S. Ma, J. Tao, W. Wang, Y. Zhou, W. Yang, and J. Cheng Genomic analysis of anti-hepatitis B virus (HBV) activity by small interfering RNA and lamivudine in stable HBV-producing cells J. Virol. 79 2005 14392 14403 (Pubitemid 41552736)
8. A. Hörmann, B. Chaudhuri, and H. Fretz DNA binding properities of the marine sponge pigment fascaplysin Bioorgan. Med. Chem. 9 2001 917 921 (Pubitemid 32448111)
9. M.G. Levee, M.I. Dabrowska, J.L. Lelli Jr., and D.B. Hinshaw Actin polymerization and depolymerization during apoptosis in HL-60 cells Am. J. Physiol. Cell Physiol. 271 1996 C1981 C1992 (Pubitemid 27030577)
10. J. Lin, X.J. Yan, and H.M. Chen Fascaplysin, a selective CDK4 inhibitor, exhibit anti-angiogenic activity in vitro and in vivo Cancer Chemoth. Pharm. 59 2007 439 445 (Pubitemid 46122322)
11. X. Liu, H. Zou, C. Slaughter, and X.D. Wang DFF, a heterodimeric protein that functions downstream of caspase-3 to trigger DNA fragmentation during apoptosis Cell 89 1997 175 184 (Pubitemid 27199890)
12. X.L. Lu, Y.L. Zheng, H.M. Chen, X.J. Yan, F. Wang, and W.F. Xu Anti-proliferation of human cervical cancer Hela cell line by fascaplysin through apoptosis induction Acta Pharmaceut. Sin. 44 2009 980 986
13. S. Mahale, C. Aubry, P.R. Jenkins, J.D. Maréchal, M.J. Sutcliffe, and B. Chaudhuri Inhibition of cancer cell growth by cyclin dependent kinase 4 inhibitors synthesized based on the structure of fascaplysin Bioorg. Chem. 34 2006 287 297 (Pubitemid 44374637)
14. S. Mahale, C. Aubry, A.J. Wilson, P.R. Jenkins, J.D. Maréchal, M.J. Sutcliffe, and B. Chaudhuri CA224, a non-planar analogue of fascaplysin, inhibits Cdk4 but not Cdk2 and arrests cells at G0/G1 inhibiting pRB phosphorylation Bioorg. Med. Chem. Lett. 16 2006 4272 4278
15. T. Mashima, M. Naito, and T. Tsuruo Caspase-mediated cleavage of cytoskeletal actin plays a positive role in the process of morphological apoptosis Oncogene 18 1999 2423 2430 (Pubitemid 29206155)
16. W.E. Mercer, M.T. Shields, D. Lin, E. Appella, and S.T. Ullrich Growth suppression induced by wild-type p53 protein is accompanied by selective down-regulation of proliferating-cell nuclear antigen expression Proc. Natl. Acad. Sci. USA 88 1991 1958 1962 (Pubitemid 21916346)
17. O.S. Radchenko, V.L. Novikov, and G.B. Elyakov A simple and practical approach to the synthesis of the marine sponge pigment fascaplysin and related compounds Tetrahedron. Lett. 38 1997 5339 5342 (Pubitemid 27300196)
18. N.L. Segraves, S.J. Robinson, D. Garcia, S.A. Said, X. Fu, F.J. Schmitz, H. Pietraszkiewicz, F.A. Valeriote, and P. Crews Comparison of fascaplysin and related alkaloids: a study of strudtues, cytotoxicities, and sources J. Nat. Prod. 67 2004 783 792 (Pubitemid 38702733)
19. N. Sera, A. Kawakami, T. Nakashima, H. Nakamura, M. Imaizumi, T. Koji, Y. Abe, T. Usa, T. Tominaga, E. Ejima, K. Ashizawa, N. Yokoyama, N. Ishikawa, K. Ito, and K. Eguchi Fas/FasL mediated apoptosis of thyrocytes in graves' disease Clin. Exp. Immunol. 124 2001 197 207 (Pubitemid 32587603)
20. R. Soni, L. Muller, P. Furet, J. Schoepfer, C. Stephan, S. Zumstein-Mecker, H. Fretz, and B. Chaudhuri Inhibition of cyclin-dependent kinase 4 (Cdk 4) by fascaplysin, a marine natural product Biochem. Biophys. Res. Commun. 275 2000 877 884
21. B. Subramanian, A. Nakeff, K. Tenney, P. Crews, L. Gunatilaka, and F. Valeriote A new paradigm for the development of anticancer agents from natural products J. Exp. Ther. Oncol. 5 2006 195 204 (Pubitemid 43843830)
22. M. Tewari, W.G. Telford, R.A. Miller, and V.M. Dixit CrmA, a poxvirus-encoded serpin, inhibits cytotoxic T-lymphocyte-mediated apoptosis J. Biol. Chem. 270 1995 22705 22708
23. H.C. Thoms, M.G. Dunlop, and L.A. Stark CDK4 inhibition and apoptosis: a novel mechanism requiring nucleolar targeting of RelA Cell Cycle 6 2007 1293 1297 (Pubitemid 47327959)
24. H.C. Thoms, M.G. Dunlop, and L.A. Stark P38-mediated inactivation of cyclin D1/cyclin-dependent kinase 4 stimulates nucleolar translocation of RelA and apoptosis in colorectal cancer cells Cancer Res. 67 2007 1660 1669 (Pubitemid 46383392)
25. S. Tu, and R.A. Cerione Cdc42 is a substrate for caspases and influences Fas-induced apoptosis J. Biol. Chem. 276 2001 19656 19663
26. A. Wang, R. Schneider-Broussard, A.P. Kumar, M.C. Macleod, and D.G. Johnson Regulation of BRCA1 expression by the Rb-E2F pathway J. Biol. Chem. 275 2000 4532 4536 (Pubitemid 30094700)
27. W. Xie, P. Jiang, L. Miao, Y. Zhao, Z. Zhai, L. Qing, W.G. Zhu, and M. Wu Novel link between E2F1 and Smac/DIABLO: proapoptotic Smac/DIABLO is transcriptionally upregulated by E2F1 Nucleic Acids Res. 34 2006 2046 2055 (Pubitemid 44314203)
28. G.X. Zhu, S.E. Conner, X. Zhou, C. Shih, T. Li, B.D. Anderson, H.B. Brooks, R.M. Campbell, E. Considine, J.A. Dempsey, M.M. Faul, C. Ogg, B. Patel, R.M. Schultz, C.D. Spencer, B. Teicher, and S.A. Watkins Synthesis, structure-activity relationship, and biological studies of indolocarbazoles as potent cyclin D1-CDK4 inhibitors J. Med. Chem. 46 2003 2027 2030 (Pubitemid 36583483)